HeartSciences (HSCS) Debt Ratio (2022 - 2026)

HeartSciences (HSCS) reported Debt Ratio of 0.06 for Q1 2026, up 777.29% quarter-over-quarter from 0.01 in Q4 2024.

HeartSciences (HSCS) Debt Ratio (2022 - 2026) Analysis & Trends

HeartSciences has reported Debt Ratio for 4 years, with the latest figure at 0.06 in Q1 2026.

  • For the quarter ending Q1 2026, Debt Ratio changed N/A year-over-year to 0.06; the trailing twelve-month figure through Jan 2026 stood at 0.06 (changed N/A YoY), and the FY2023 full-year result was 0.15, down 92.84% from the prior year.
  • Debt Ratio for Q1 2026 stood at 0.06, up from 0.01 in the prior quarter.
  • The five-year high for Debt Ratio was 2.13 in Q2 2022, with the low at 0.01 in Q4 2024.
  • Historically, Debt Ratio has averaged 0.38 across 4 years, with a median of 0.17 in 2022.
  • The largest YoY upside for Debt Ratio was 7.15% in 2023 against a maximum downside of 92.84% in 2023.
  • HeartSciences' Debt Ratio stood at 0.18 in 2022, then advanced by 7.15% to 0.19 in 2023, then tumbled by 96.7% to 0.01 in 2024, then soared by 777.29% to 0.06 in 2026.
  • The last three Debt Ratio figures came in at 0.06 (Q1 2026), 0.01 (Q4 2024), and 0.06 (Q3 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn 0.31
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn 0.32
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn 0.31
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn 0.25
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn 0.04
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 0.30
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn 0.27
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn 0.18
10 HeartSciences 3.89 Mn 492,884.20 - 0.06

Historic Data

Download Data
DateValue
Jan 31, 2026 0.06
Oct 31, 2024 0.01
Jul 31, 2024 0.06
Jul 31, 2023 0.19
Apr 30, 2023 0.15
Jan 31, 2023 0.29
Jul 31, 2022 0.18
Apr 30, 2022 2.13